HomeHealthReuters reveals India's PharmEasy plans $200 million fundraising at decrease valuation

Reuters reveals India’s PharmEasy plans $200 million fundraising at decrease valuation

Well being

Reuters was first to report that Indian drug and medical providers startup PharmEasy is in talks with buyers to lift $200 million, however at a valuation that might be 15% and even 25% decrease than final 12 months’s $5.1 billion. Indian startups have been jolted by unsure international and home inventory markets and rising investor skepticism over what they are saying are sky-high valuations, making it tough for PharmEasy to lift funds at similar or the next valuation. 

Article Tags

Matters of Curiosity: Well being

Kind: Reuters Greatest

Sectors: Prescription drugs & Healthcare

Areas: Asia

Nations: India

Win Varieties: Exclusivity

Story Varieties: Unique / Scoop

Media Varieties: Textual content

Buyer Affect: Vital Nationwide Story

Supply hyperlink



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments